5E Advanced Materials heads into the post-earnings week in a curious position: the stock fell 16% this week while the short sellers who drove that pressure quietly exited.
The standout this week is the collapse in short interest. Estimated short positions plunged 74% over the five trading days to May 12, dropping from roughly 3.36% of the float on May 5 to just 0.87% now. That unwinding is sharp enough to suggest a cover trade — not a gradual fade — but it has not provided the stock with any lift. The share price closed at $1.51 on Tuesday, down 7% on the day and 16% across the week, pointing to selling pressure from other quarters rather than a short-driven move.
The lending market confirms this is not a squeeze story. Borrow costs remain unremarkable at around 4.1% annually, roughly where they have traded since April. The utilisation of available borrow has fallen steeply, too — from over 33% at the start of May to just 16.7% now, well below the 52-week peak of 69%. Taken together, those readings describe a stock where the short community has stepped away rather than one where they are under pressure. The ORTEX short score has followed the same path, sliding from 50.7 on May 1 to 35.7 today — moving from a moderate bearish signal toward neutral territory in under two weeks.
The catalyst for the week's activity was the Q3 2026 earnings release on May 12. FEAM beat EPS expectations by $0.01, a slim but technically positive surprise. More meaningfully, the company announced its first milestone offtake Heads of Agreement with a domestic industrial customer — a tangible step toward the commercial production that has been the story's central promise. The company also disclosed progress on a magnet-grade ferroboron development programme at the Fort Cady project, adding a new downstream angle to what has so far been a pure boron supply play. Despite those developments, the stock sold off hard on the day, echoing the February 17 earnings response when FEAM dropped 16.7% the next session and a further 15% by day five.
On the Street, the picture remains thin but directionally consistent. HC Wainwright today lowered its price target by $0.25 to $5.50 while maintaining its Buy rating — a modest trim that preserves the bullish thesis even as the target drifts lower over time. The current mean target of $4.88 against a $1.51 close implies substantial upside on paper, though the repeated target reductions — from $9.25 last November to $5.75 in March to $5.50 today — describe a coverage trajectory that has been persistently revising down. The bull case rests on boron's critical-mineral status, cost reductions at Fort Cady, and the new offtake agreement. The bear case is grounded in continued net losses ($10.7 million in the most recent period) and the reality that commercial production remains ahead, not behind.
Ownership is heavily concentrated in a handful of strategic holders. Bluescape Energy Partners holds 29% of shares, Ascend Capital just over 20%, and AWM Investment Company added a fresh 3.07 million share position as of March 31. Together the top three holders control more than 56% of the register. That concentration limits float and amplifies any move — in either direction — when sentiment shifts.
The next significant data point to watch is whether the new offtake agreement progresses beyond a Heads of Agreement to a binding contract, and whether further cost benchmarks from the Fort Cady small-scale facility point to project economics that can attract additional institutional support.
See the live data behind this article on ORTEX.
Open FEAM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
